Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits.
about
The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsOverlapping Chronic Pain Conditions: Implications for Diagnosis and Classification.Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in JapanBiomarkers to distinguish functional constipation from irritable bowel syndrome with constipation.Role of antispasmodics in the treatment of irritable bowel syndrome.Mild moxibustion decreases the expression of prokineticin 2 and prokineticin receptor 2 in the colon and spinal cord of rats with irritable bowel syndromeIrritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndromeAltered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuliPooled analysis of brain activity in irritable bowel syndrome and controls during rectal balloon distension.Fecal protease activity is associated with compositional alterations in the intestinal microbiota.Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.Association between intimate partner violence and irritable bowel syndrome: a population-based study in NicaraguaSuspended moxibustion at Tianshu (ST25) inhibits prokineticin 1 and prokineticin receptor 1 expression in the spinal cord of rats with chronic visceral hypersensitivityLubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndromeEvidence-based clinical practice guidelines for irritable bowel syndrome.No association between the common calcium-sensing receptor polymorphism rs1801725 and irritable bowel syndrome.Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome.Alternative procedure to shorten rectal barostat procedure for the assessment of rectal compliance and visceral perception: a feasibility study.Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS)Acupuncture transcutaneous electrical nerve stimulation reduces discomfort associated with barostat-induced rectal distension: a randomized-controlled study.Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model.Thermal hypersensitivity in a subset of irritable bowel syndrome patientsRectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.Development and validation of new disease-specific measures of somatization and comorbidity in IBS.Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysisEvaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea.Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.Is irritable bowel syndrome an organic disorder?Treatment of abdominal pain in irritable bowel syndrome.Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.Recent advances in the diagnosis of irritable bowel syndrome.Systematic review: instruments to assess abdominal pain in irritable bowel syndrome.Development and validation of a risk score for post-infectious irritable bowel syndrome.Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?Expression of the nociceptin/orphanin FQ receptor in the intestinal mucosa of IBS patients.Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.Interaction between preprandial and postprandial rectal sensory and motor abnormalities in IBS.Mechanisms of Stress-induced Visceral Pain.
P2860
Q26739291-5878609F-4EE6-48B4-BFF9-0DE3A064B175Q30248205-8161E592-2FA3-4629-8014-DCA3007C49F2Q30382064-AA4599D0-D8B2-44CB-A0D8-1F5FA33D4EB2Q31099942-79FEF80A-43FA-437F-8782-2A022EC6343FQ33661077-30FD23DE-7C7E-4778-B0A2-91B8C440A389Q33850023-52F4E5F1-2841-464B-B20B-0AA1AB844DF1Q34273007-5E4AD111-83BA-45B9-B281-E34777705720Q34407924-9607C571-7AC1-4BAD-897D-1CECE16D7C7FQ34827191-A77C3907-41BB-4AE6-AB32-584C2F10BFE6Q34887939-32376552-DB09-4184-8483-39DC85470B43Q35017066-D4AAD27A-1E58-478C-9552-4323EC3CD842Q35023520-6F1A1D3D-ED3A-4524-887F-1DFBFC613B54Q35043139-E047F4E7-A674-4C8F-BEA7-6EA91EB662CBQ35079562-2AE2A873-0A60-4E26-BAE5-FA4716E28F2BQ35120172-EB556751-4910-4D03-BF82-2F1E27C29768Q35251195-65A3AA57-053A-469A-B308-FD1A8D4389EBQ35513973-2EBF99E1-2397-4771-B15C-DB70945FDD24Q35865545-7334D184-39C0-4774-BD47-FABC70B188ACQ35903549-68355A62-DDEB-4013-BD46-9B840AA491EFQ36177244-EB7DC8E2-4DB8-4B71-BBF5-E7EE5C69862AQ36539600-FDBEB4D8-FCFB-43AC-90E4-30BAD460CBAEQ36561666-58324F3B-8ADC-4114-A816-ECDC72E5DADCQ36904014-124F3715-2C40-449D-AF4F-EAC8611EDEBAQ37262053-3FC840D6-98FB-47B8-9533-405E32130E35Q37356418-04103542-C885-49EC-A67C-3915E0C1B6CBQ37373916-473A5C79-6325-4558-AF02-705DB9C6A5D6Q37638787-6F3C9A9E-1D86-4DC6-89AE-C55C0A726DA8Q37694028-EAADB659-3EAF-42C6-99C6-ADC290ED79AFQ37708383-2D5A6D87-6FB2-4521-8C4D-C2A6275253EBQ38191561-8901F683-9BFB-4F03-9F1C-07E99678A2C8Q38213185-F4077301-A055-4972-97E0-35A1AE35CAAAQ38334245-5C15D0E6-E7E5-47A9-BCE5-2F476ECC30B8Q38545062-457E5DA0-D91F-4EE9-9088-AE38CB65C333Q38569948-25C61405-D8F1-4ABE-8F71-09F311EACF8DQ40385600-36F00CD9-F330-498D-9D18-67362BA7AA59Q41173004-D2E95CB5-6B15-4FF1-A73B-1DDAA63CFCB1Q42088311-82220EF6-7F92-46B4-AACD-FDB2556975FCQ43336624-4867F15F-9FC4-4407-96E6-3259E7AEAF74Q43426450-684930E4-97FC-4E7C-964F-F30B6EFF068AQ47153705-5A174B00-D2F6-4230-96B2-656DE7E50AC3
P2860
Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contributions of pain sensitiv ...... and predominant bowel habits.
@en
Contributions of pain sensitiv ...... and predominant bowel habits.
@nl
type
label
Contributions of pain sensitiv ...... and predominant bowel habits.
@en
Contributions of pain sensitiv ...... and predominant bowel habits.
@nl
prefLabel
Contributions of pain sensitiv ...... and predominant bowel habits.
@en
Contributions of pain sensitiv ...... and predominant bowel habits.
@nl
P2093
P2860
P1476
Contributions of pain sensitiv ...... and predominant bowel habits.
@en
P2093
Denesh K Chitkara
Douglas A Drossman
Lisa M Gangarosa
Marsha J Turner
Miranda A L van Tilburg
Motoyori Kanazawa
Olafur S Palsson
Shin Fukudo
Syed I M Thiwan
William E Whitehead
P2860
P304
P356
10.1111/J.1572-0241.2008.02066.X
P407
P577
2008-08-05T00:00:00Z